Monday, December 1, 2008 - 10:51PM EST

General Interest Articles

21. Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.

Author
Shariat SF; Ashfaq R; Karakiewicz PI; Saeedi O; Sagalowsky AI; Lotan Y;
Institution
Department of Urology, University of Texas Southwestern Medical Center at Dallas, Texas 75390-9110, USA. Shahrokh.Shariat@UTSouthwestern.edu
Journal
Cancer. 2007 Mar 15;109(6):1106-13.
Abstract URL
Click here to view abstract

22. Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha.

Author
Esuvaranathan K; Chiong E; Thamboo TP; Chan YH; Kamaraj R; Mahendran R; Teh M;
Institution
Department of Surgery, National University of Singapore, Singapore. suresuva@nus.edu.sg
Journal
Cancer. 2007 Mar 15;109(6):1097-105.
Abstract URL
Click here to view abstract

23. Survivin: A promising tumor biomarker.

Author
Duffy MJ; O'donovan N; Brennan DJ; Gallagher WM; Ryan BM;
Institution
Department of Pathology and Laboratory Medicine, St. Vincent's University Hospital, Dublin 4, Ireland; UCD School of Medicine and Medical Science, University College Dublin, Dublin 4, Ireland.
Journal
Cancer Lett. 2007 Apr 28;249(1):49-60. Epub 2007 Feb 1.
Abstract URL
Click here to view abstract

24. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke.

Author
Alberg AJ; Kouzis A; Genkinger JM; Gallicchio L; Burke AE; Hoffman SC; Diener-West M; Helzlsouer KJ; Comstock GW;
Institution
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. alberg@musc.edu
Journal
Am J Epidemiol. 2007 Mar 15;165(6):660-6. Epub 2007 Jan 4.
Abstract URL
Click here to view abstract

25. Where are we with the treatment of metastatic bladder cancer?

Author
Papatsoris AG; Kachrilas S; Gekas A;
Institution
Agios Andreas Regional Hospital, Department of Urology, Patras, Greece. agpapatsoris@yahoo.gr
Journal
Expert Opin Investig Drugs. 2007 Sep;16(9):1311-4.
Abstract URL
Click here to view abstract

26. Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer.

Author
Weizer AZ; Joshi D; Daignault S; Kinnaman M; Hussain M; Montie JE; Zhang Y; Lee CT;
Institution
Department of Urology, University of Michigan, Ann Arbor, Michigan 48109, USA.
Journal
J Urol. 2007 Apr;177(4):1287-93.
Abstract URL
Click here to view abstract

27. Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer.

Author
Raj GV; Herr H; Serio AM; Donat SM; Bochner BH; Vickers AJ; Dalbagni G;
Institution
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Journal
J Urol. 2007 Apr;177(4):1283-6; discussion 1286.
Abstract URL
Click here to view abstract

28. Angiosarcoma of bladder: long-term survival after multimodal therapy.

Author
Pazona JF; Gupta R; Wysock J; Schaeffer AJ; Smith ND;
Institution
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
Journal
Urology. 2007 Mar;69(3):575.e9-10.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4